Xeplion CH (Paliperidone Vials) 100 mg/ml

Xeplion CH (paliperidone) is an injectable atypical antipsychotic in vials (100 mg/ml) for schizophrenia and schizoaffective disorder management. Designed for long-acting symptom control with convenient dosing schedules. Suitable for adults seeking sustained relief from psychotic symptoms.

Strength

100 mg/ml

Pack Size

Storage

Ambient

Manufacturer / TM Owner

JANSSEN-CILAG AG

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Xeplion CH is used to treat schizophrenia and schizoaffective disorder by helping stabilize mood and reduce symptoms like hallucinations or delusions. It works gradually over weeks to support long-term mental health management. Commonly prescribed when oral medications are challenging to maintain consistently.

Side Effects

Many users report improved focus and reduced agitation within the first few weeks of starting Xeplion CH. Some experience mild soreness at the injection site or temporary drowsiness as the body adjusts to the medication. These effects typically lessen as treatment continues.

Precautions & Warnings

Store Xeplion CH at room temperature away from moisture and direct light. Keep out of reach of children and pets. Always follow healthcare provider instructions for use and disposal of vials. Report any unusual reactions to a medical professional promptly.

Avoid Interactions

Avoid alcohol while using Xeplion CH as it may increase drowsiness or dizziness. Certain medications, such as strong CYP3A4 inhibitors or inducers, can affect paliperidone levels in the blood. Inform your doctor about all prescription and over-the-counter products you are taking.

Frequently Asked Questions

Xeplion CH is used to manage symptoms of schizophrenia and schizoaffective disorder in adults.

Xeplion CH is given as an intramuscular injection by a healthcare professional, typically once monthly.

Some users may experience weight changes while taking Xeplion CH; discuss concerns with your healthcare provider.

No, Xeplion CH is not classified as a controlled substance but requires a prescription.

Avoid alcohol and consult your doctor before taking other medications or supplements to prevent interactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.